Nykredit A S Buys Shares of 48,302 McKesson Corporation $MCK

Key Points

• Nykredit A/S acquired 48,302 McKesson shares during the second quarter, valued at approximately $36.5 million. Institutional investors and hedge funds collectively own 85.07% of the company.
• McKesson exceeded quarterly expectations, reporting $9.93 EPS and $105.38 billion in revenue, with revenue up 7.7% year over year. The company provided fiscal 2027 EPS guidance of $44.20–$45.00.
• The company increased its quarterly dividend from $0.82 to $0.94 per share, while analysts maintained a “Moderate Buy” consensus and an average price target of $973.44.

Nykredit A S purchased a new position in McKesson Corporation (NYSE:MCK - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 48,302 shares of the company's stock, valued at approximately $36,497,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Delos Wealth Advisors LLC acquired a new stake in shares of McKesson during the 2nd quarter worth approximately $27,000. Kingdom Financial Group LLC. acquired a new stake in McKesson in the fourth quarter worth $33,000. Greykasell Wealth Strategies Inc. lifted its stake in McKesson by 104.8% in the fourth quarter. Greykasell Wealth Strategies Inc. now owns 43 shares of the company's stock valued at $35,000 after buying an additional 22 shares during the last quarter. Clearstead Trust LLC bought a new stake in McKesson in the second quarter valued at $37,000. Finally, Evelyn Partners Investment Management Services Ltd acquired a new position in shares of McKesson during the first quarter valued at $45,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Price Performance

Shares of NYSE:MCK opened at $874.02 on Friday. The stock has a market cap of $101.90 billion, a price-to-earnings ratio of 23.39, a PEG ratio of 1.75 and a beta of 0.30. McKesson Corporation has a 12 month low of $687.68 and a 12 month high of $999.00. The stock's 50 day moving average price is $869.09 and its 200 day moving average price is $838.65.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The firm had revenue of $105.38 billion during the quarter, compared to analyst estimates of $103.88 billion. During the same period last year, the company posted $8.26 EPS. The firm's quarterly revenue was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, sell-side analysts expect that McKesson Corporation will post 44.64 EPS for the current year.

McKesson Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be issued a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 1st. This is a positive change from McKesson's previous quarterly dividend of $0.82. McKesson's dividend payout ratio is currently 10.06%.

Insider Activity

In related news, CEO Brian Tyler sold 8,463 shares of the business's stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total value of $6,715,898.28. Following the sale, the chief executive officer directly owned 5,919 shares in the company, valued at $4,697,081.64. The trade was a 58.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley Lerman sold 301 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 8,875 shares of company stock worth $7,083,441. Corporate insiders own 0.06% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. TD Cowen increased their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Barclays boosted their target price on shares of McKesson from $925.00 to $1,000.00 and gave the company an "overweight" rating in a research note on Wednesday, August 19th. Evercore restated an "outperform" rating on shares of McKesson in a research report on Thursday, August 6th. Weiss Ratings upgraded shares of McKesson from a "buy (b-)" rating to a "buy (b)" rating in a research note on Friday, September 4th. Finally, Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $845.00 price target on shares of McKesson in a report on Monday, September 14th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $973.44.

McKesson Profile

McKesson Corporation is a healthcare services and distribution company that supplies pharmaceuticals, specialty drugs, medical products and related services to pharmacies, hospitals, health systems, physicians and other healthcare providers. Its operations support the movement of prescription medicines and medical-surgical supplies from manufacturers to healthcare organizations and patients.

The company's businesses include pharmaceutical distribution, specialty pharmaceutical services, medical-surgical supply distribution and technology solutions for pharmacies and other healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.